Eli Lilly’s Obesity Pill & Tim Cook at the White House 8/7/25
President Trump has announced he will impose a 100% tariff on chips and semiconductors imports, although he’s suggested exemptions for companies manufacturing in the U.S. One company that may qualify for that exemption: Apple. During CEO Tim Cook’s meeting with the President on Wednesday, Cook committed an additional $100 billion to onshore manufacturing. Author Walter Isaacson discusses Cook’s commitment in the context of Steve Jobs’ original plans to manufacture Apple products in America. President Trump also has another tech CEO in his sights, calling for the resignation of Intel’s Lip-Bu Tan on social media. CNBC’s Angelica Peebles reveals the latest obesity pill trial results from Eli Lilly. Orfoglipron’s results were similar to Wegovy, and investors are disappointed by the data and the rate of discontinuation among trial participants. Plus, Lyft CEO David Risher explains his company’s earnings report, strong on paper but disappointing to some investors. Megan Cassella - 5:35 Angelica Peebles - 13:03 Walter Isaacson - 20:47 David Risher - 35:21 In this episode: Megan Cassella, @mmcassella Angelica Peebles, @angelicapeebles Joe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkin Melissa Lee, @MelissaLeeCNBC Katie Kramer, @Kramer_Katie
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
President Trump has announced he will impose a 100% tariff on chips and semiconductors imports, although he’s suggested exemptions for companies manufacturing in the U.S. One company that may qualify for that exemption: Apple. During CEO Tim Cook’s meeting with the President on Wednesday, Cook committed an additional $100 billion to onshore manufacturing. Author Walter Isaacson discusses Cook’s commitment in the context of Steve Jobs’ original plans to manufacture Apple products in America. President Trump also has another tech CEO in his sights, calling for the resignation of Intel’s Lip-Bu Tan on social media. CNBC’s Angelica Peebles reveals the latest obesity pill trial results from Eli Lilly. Orfoglipron’s results were similar to Wegovy, and investors are disappointed by the data and the rate of discontinuation among trial participants. Plus, Lyft CEO David Risher explains his company’s earnings report, strong on paper but disappointing to some investors.
Megan Cassella - 5:35
Angelica Peebles - 13:03
Walter Isaacson - 20:47
David Risher - 35:21
In this episode:
Megan Cassella, @mmcassella
Angelica Peebles, @angelicapeebles
Joe Kernen, @JoeSquawk
Andrew Ross Sorkin, @andrewrsorkin
Melissa Lee, @MelissaLeeCNBC
Katie Kramer, @Kramer_Katie
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.